AI in Insurance: Partnering with ResiQuant to Turn Catastrophe Risk into Resilience with AI-Powered Property Intelligence Platform

AI in Insurance: Partnering with ResiQuant to Turn Catastrophe Risk into Resilience with AI-Powered Property Intelligence Platform

We are very excited to partner with the fantastic deep tech team at ResiQuant that is developing a platform that utilizes agentic AI and computer vision to transform data into actionable, building-level insights. This empowers property owners and carriers to mitigate vulnerabilities, streamline workflows and enhance underwriting decisions.

We at LDV Capital led their $4M seed round with participation from Foothill Ventures, Pear VC, Alumni Ventures and angels.

Read More

3 Years Investing at LDV Capital: Insights from Sourcing, Evaluating & Partnering with Early-Stage Deep Tech Founders

3 Years Investing at LDV Capital: Insights from Sourcing,  Evaluating & Partnering with Early-Stage Deep Tech Founders

In September 2021, Ash Cleary began his venture capital journey by joining Evan Nisselson and our LDV Capital team as an Analyst, investing out of Fund III as part of a two-year program. After successfully completing the program, Ash was promoted to Associate and now invests out of LDV Capital's fourth fund.

Check out his insights and reflections on the past three years—working with the team and collaborating with brilliant deep tech entrepreneurs worldwide, building businesses powered by visual technology and artificial intelligence.

Read More

Partnering with VitVio to Deliver Real-Time AI Visual Tracking In Hospital Operating Theatres to Increase Efficiencies

Partnering with VitVio to Deliver Real-Time AI Visual Tracking In Hospital Operating Theatres to Increase Efficiencies

We are excited to partner and invest in the brilliant VitVio team. They are building an AI-driven computer vision platform designed to enhance the safety and efficiency of hospital operating theaters.

We at LDV Capital led their $2M pre-seed round with participation from Bek Ventures (ex-Earlybird), Tiny Supercomputer Investment Company, and angel investors.

VitVio has also announced their pilot program with the Royal Orthopaedic Hospital (ROH), one of the UK's three leading medical institutions in orthopedic care and “one of the best hospitals in the world.”

Read More

Visual Technologies Are Fueling the Transition To a Circular Economy

Visual Technologies Are Fueling the Transition To a Circular Economy

LDV Capital's Evan Nisselson and Ash Cleary cover topics ranging from spectroscopy and nanomaterials to enhance food and agricultural production, to renewable energy forecasting and grid management, and predictive digital twins for the supply chain.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

Meet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.

If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.

Read More

Meta’s Matt Uyttendaele on AI for Material Discovery

Meta’s Matt Uyttendaele on AI for Material Discovery

Matt Uyttendaele is the director of the AI for Chemistry group at Meta. His group applies machine learning to material discovery for several applications: clean hydrogen, sorbents for direct air capture, and next-generation displays. In 2024, we were honored to have him speak at our Annual General Meeting about a new application of AI that he has been working on for the last few years and how it relates to his career in visual technologies.

Read More

Visual Tech Advancements in Life Sciences & Biotech Paving the Way for Longer and Healthier Lives

Visual Tech Advancements in Life Sciences & Biotech Paving the Way for Longer and Healthier Lives

As the biotech industry heavily relies on data filtering, analysis, and sharing, visual technologies play a critical role in detecting and imaging biological systems. This paves the way for the future of life sciences tools, enabling next-generation therapeutics, biomanufacturing, and longevity. At our 10th Annual LDV Vision Summit earlier this year, a panel of experts delved into these topics and explored various critical aspects shaping the future of biotechnology. Check out their insights.

Read More

Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

We at LDV Capital celebrated our 10th LDV Vision Summit Anniversary! People from over 30 countries were part of our premier global gathering in visual tech & AI. We were thrilled to welcome speakers from Sequoia Capital, Wellville, Generate:Biomedicines, DCVC Bio, Princeton University, Stanford University, University of California, Nobias Therapeutics, Snap, Future Ventures, Meta, Axios and more. Two of our LDV Capital portfolio companies presented as well: Synthesia and Sonus Microsystems.

Read More

Structuring a Sustainable Future: Visual Technology is Advancing the Discovery & Development of New Materials

Structuring a Sustainable Future: Visual Technology is Advancing the  Discovery & Development of New Materials

We believe that visual technologies will continue to be the crux of advancements in materials science, across nanomaterials and metamaterials, resulting in the transformation of various industrial, medical and consumer applications. Embedded AI will enable materials to reconfigure themselves autonomously in response to their environment. As sensing abilities and algorithms improve, the full potential of navigating the compositional and configurational possibilities of materials will catalyze widespread transformation for optics, biomarker diagnostics, robotics, 3D printing and more.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

On March 21, at our 10th Annual LDV Vision Summit, Evan Nisselson, Founder and General Partner at LDV Capital, will speak with Dr. Molly Gibson – Co-Founder and Chief Strategy and Innovation Officer at Generate:Biomedicines. They will discuss how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials, and more. This will have a tremendous impact on business and society. 

In the lead-up to the Summit, Evan had the privilege of asking Dr. Gibson a few questions.

Read More

Living Longer & Healthier: How Visual Tech will Advance Accelerations in Life Sciences & Biotech

Living Longer & Healthier: How Visual Tech will Advance Accelerations in Life Sciences & Biotech

As the biotech industry relies heavily on data filtering, analysis and sharing, visual technologies will become critical for the detection and imaging of biological systems, paving the way for the future of life sciences tools enabling next-generation therapeutics, biomanufacturing & longevity.

Read More

LDV Community Helping Entrepreneurs Succeed For 11 Years

LDV Community Helping Entrepreneurs Succeed For 11 Years

Thrilled to present a selection of photos capturing moments from our recent invite-only "Happy Hour" event, held in New York City. This event brought together outstanding technology innovators, serial entrepreneurs, deep tech researchers, and investors from within the vibrant New York tech ecosystem.

Read More

How and When Will Deep Tech Increase the Longevity of Humans?

How and When Will Deep Tech Increase the Longevity of Humans?

Who wants to live healthier and longer lives? Recent advancements in visual technologies, machine learning, and artificial intelligence will increase human longevity. Solutions ranging from analyzing health records, blood results, physiological test scores, body scans, biotechnologies, and even genetic tests will be a game-changer in longevity healthcare. Whether you are looking to “optimize your performance” – be that physical or cognitive performance – or interested to learn about longevity medicine able to push the limits of the human lifespan – this panel from our 9th Annual LDV Vision Summit covers that and more!

Read More

Since 2012 - Timeline of Investing In People Building Businesses Powered by Visual Tech & AI

Since 2012 - Timeline of Investing In People Building Businesses Powered by Visual Tech & AI

Last year, we celebrated 10 years of investing in people building businesses powered by visual tech & AI, but it’s just the beginning! Visual technology innovations will continue to be the crux of automation for decades and beyond. Computer vision, machine learning and AI will be the key enablers for innovation in healthcare, precision medicine, manufacturing, construction, agriculture, sustainability, and many more industries.

Read More

Insights from Ty Ahmad-Taylor’s 32 years working at NYTimes, @Home Network, Samsung, Meta, and Snap

Insights from Ty Ahmad-Taylor’s 32 years working at NYTimes, @Home Network, Samsung, Meta, and Snap

Meet Ty Ahmad-Taylor, VP of Monetization at Snap. Ty’s background: 32 years in information design, 26 years in consumer-facing software and product development leadership, and 25 years in interactive television services development. He has worked at four startups (one went public, and the other three were acquired), and at large social, media, and consumer electronic companies.

In the fireside chat with LDV’s Evan Nisselson, he shared his views on three things that every CEO should do, inclusive teams, systems thinking, and an exclusion filter that could make our experience of using social media so much better! Evan and Ty also touched on ideas ripe for AI automation, machine learning algorithms that make TikTok successful, and the mixed reality environment that’s coming soon.

Read More

Lessons from Commercializing AI Research, Starting Deep Tech Businesses & Building AI Products At Fortune 100 Companies

Lessons from Commercializing AI Research, Starting Deep Tech Businesses & Building AI Products At Fortune 100 Companies

In this fireside chat with LDV Capital General Partner Evan Nisselson, Clement Farabet, VP of Research at DeepMind, shared his views on the positives, negatives, and lessons learned from building artificial intelligence projects while at university, to founding a startup that successfully exited and at large Fortune 100 corporations.

Read More

Thank You for Being a Vital Part of Our 9th Annual LDV Vision Summit!

Thank You for Being a Vital Part of Our 9th Annual LDV Vision Summit!

At our 9th Annual LDV Vision Summit, we welcomed top technologists, investors, and entrepreneurs to discuss cutting-edge computer vision, machine learning and AI solutions to improve the world we live in.

About a thousand people tuned in from all around the world to listen to expert speakers from DeepMind, Mural, Snap, BioAge, Synthesia, Salesforce, Harvard Medical School, Insight Partners, Useful Sensors, Conviction, Niels Bohr Institute, Air Street Capital, Uizard, Pano, Humanity, Northeastern University, Seedcamp, Forbes, and more.

Read More